Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2009

Conditions
Malignant Mesothelioma
Interventions
DRUG

bortezomib

PROCEDURE

quality-of-life assessment

Trial Locations (13)

4

St. Vincent's University Hospital, Dublin

7

Mater Misericordiae University Hospital, Dublin

8

St. James's Hospital, Dublin

9

Beaumont Hospital, Dublin

24

Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin

B-9000

Universitair Ziekenhuis Gent, Ghent

Unknown

Cork University Hospital, Cork

Galway University Hospital, Galway

1066 BE

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

EC1A 7BE

Saint Bartholomew's Hospital, London

SM2 5PT

Royal Marsden - Surrey, Sutton

BT9 7BL

Centre for Cancer Research and Cell Biology at Queen's University Belfast, Belfast

G11 6NT

Beatson West of Scotland Cancer Centre, Glasgow

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT00513877 - Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter